Roles of real-world evidence in severe asthma treatment: challenges and opportunities
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Youngsoo | - |
dc.contributor.author | Lee, Ji-Hyang | - |
dc.contributor.author | Park, So Young | - |
dc.contributor.author | Lee, Ji-Ho | - |
dc.contributor.author | Kim, Joo-Hee | - |
dc.contributor.author | Kim, Hyun Jung | - |
dc.contributor.author | Kim, Sang-Heon | - |
dc.contributor.author | Chung, Kian Fan | - |
dc.contributor.author | Song, Woo-Jung | - |
dc.date.accessioned | 2023-06-01T07:05:42Z | - |
dc.date.available | 2023-06-01T07:05:42Z | - |
dc.date.created | 2023-05-16 | - |
dc.date.issued | 2023-03 | - |
dc.identifier.issn | 2312-0541 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/185873 | - |
dc.description.abstract | Recent advances in asthma research have led to the development of novel biologicals that hinder the pathological actions of key molecules in severe asthma. Traditional randomised controlled studies (RCTs), the gold standard for evaluating the efficacy and safety of medical interventions with excellent internal validity, have proven the clinical benefits and favourable safety profiles of type 2 biologicals in severe asthma. However, RCTs are not always ideal because of shortcomings such as limited external validity and practical issues in the management of severe asthma that cannot be solved through strictly designed clinical trials. Thus, the applicability of their findings may be questioned because treatment adherence is frequently poor in the real world. Real-world evidence includes a wide range of real-world data (RWD) collected from multiple sources in clinical practice, such as electronic medical records, healthcare insurance claims and retrospective or prospective patient registries. RWD may help clinicians decide how to manage patients with severe asthma. Real-world evidence is also gaining attention in addressing clinical questions not answered by traditional RCTs. Because there are various types of RWD with different possibilities and limitations, it is important to decide which type of RWD could be "fit for purpose" to address a specific question. This narrative review discusses the challenges and opportunities of RWD for evaluating the effectiveness and clinical outcomes of biological treatments for severe asthma. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | EUROPEAN RESPIRATORY SOC JOURNALS LTD | - |
dc.title | Roles of real-world evidence in severe asthma treatment: challenges and opportunities | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Kim, Sang-Heon | - |
dc.identifier.doi | 10.1183/23120541.00248-2022 | - |
dc.identifier.scopusid | 2-s2.0-85156223348 | - |
dc.identifier.wosid | 000966249000002 | - |
dc.identifier.bibliographicCitation | ERJ OPEN RESEARCH, v.9, no.2, pp.1 - 16 | - |
dc.relation.isPartOf | ERJ OPEN RESEARCH | - |
dc.citation.title | ERJ OPEN RESEARCH | - |
dc.citation.volume | 9 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 1 | - |
dc.citation.endPage | 16 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Respiratory System | - |
dc.relation.journalWebOfScienceCategory | Respiratory System | - |
dc.subject.keywordPlus | SEVERE ALLERGIC-ASTHMA | - |
dc.subject.keywordPlus | SEVERE EOSINOPHILIC ASTHMA | - |
dc.subject.keywordPlus | RANDOMIZED CONTROLLED-TRIALS | - |
dc.subject.keywordPlus | EXTERNAL VALIDITY | - |
dc.subject.keywordPlus | SECONDARY DATA | - |
dc.subject.keywordPlus | DOUBLE-BLIND | - |
dc.subject.keywordPlus | OPEN-LABEL | - |
dc.subject.keywordPlus | OMALIZUMAB | - |
dc.subject.keywordPlus | MEPOLIZUMAB | - |
dc.subject.keywordPlus | LIFE | - |
dc.identifier.url | https://openres.ersjournals.com/content/9/2/00248-2022 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.